StockClub

SRPT

SRPTSarepta Therapeutics, Inc.$ --
Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

SRPT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
731M USD
YoY -1.9%
Operating Income
358M USD
YoY +219.3%
Net Income
331M USD
YoY +174.0%
EPS
3.15$
YoY +168.5%

Revenue

$730.8M
FY2024 Q2$776.4M
$776.4M
Q2
FY2024 Q3$1.2B
$1.2B
Q3
FY2024 Q4$1.9B
$1.9B
Q4
FY2025 Q1$744.9M
$744.9M
Q1
FY2025 Q2$1.4B
$1.4B
Q2
FY2025 Q3$1.8B
$1.8B
Q3
FY2025 Q4$2.2B
$2.2B
Q4
FY2026 Q1$730.8M
$730.8M
Q1
Actual
$-14.1M (-1.9%)

Net Income

$331M
FY2024 Q2$42.6M
$42.6M
Q2
FY2024 Q3$76.2M
$76.2M
Q3
FY2024 Q4$235.2M
$235.2M
Q4
FY2025 Q1$-447.5M
$-447.5M
Q1
FY2025 Q2$-250.6M
$-250.6M
Q2
FY2025 Q3$-430.6M
$-430.6M
Q3
FY2025 Q4$-713.4M
$-713.4M
Q4
FY2026 Q1$331M
$331M
Q1
Actual
+$778.5M (+174.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$540.1M
Est:$540.2M
FY2020MISS
$540.1M
FY2021BEAT
Actual:$701.9M
Est:$695.4M
FY2021BEAT
$701.9M
FY2022BEAT
Actual:$933M
Est:$924.7M
FY2022BEAT
$933M
FY2023MISS
Actual:$1.2B
Est:$1.5B
FY2023MISS
$1.2B
FY2024BEAT
Actual:$1.9B
Est:$1.8B
FY2024BEAT
$1.9B
FY2025BEAT
Actual:$2.2B
Est:$1.9B
FY2025BEAT
$2.2B

Analyst Estimates